Home / Stockholms Medicinska Biobank / The COVID-19 Immunity study
Collection
The COVID-19 Immunity study
Description: The COMMUNITY pandemic surveillance cohort was initiated in April 2020 and comprises 2149 healthcare workers and 118 COVID-19 patients. Blood samples are collected every four months. Serological and cellular immune responses are continuously mapped to demography, vaccination(s) and prior infection. qPCR screening programs, including viral sequencing and culturing, are conducted during time points with high viral transmission and in response to the threat of emerging variants of concern (VOC).
Acronym:
COMMUNITY
Biobank:
Stockholms Medicinska Biobank
Local collection ID (within the biobank):
N/A
General information
Collection size:
10.000 - 100.000
(as of 2022-05-17)
Type:
Disease specific
Hospital
Sample
Data:
Biological samples
Medical records
Start date of sampling:
2020-04-01
Ethical approval number:
2020-01653
Donor information
Number of donors:
1000 - 10.000
Samples from deceased (autopsy):
no
Samples from minors (<18 years old):
no
Inclusion criteria: COVID-19 patients admitted to Danderyd hospital. Inclusion criterion was COVID-19 diagnosis based on reverse-transcriptase polymerase chain reaction viral RNA detection of nasopharyngeal or oropharyngeal swabs or clinical presentation. Healthcare workers at Danderyd hospital.
Sample information
Materials:
Collection contact information
Collection head: Charlotte Thålin
Contact person: Charlotte
Thålin
charlotte.thalin@ki.se
Biobank contact information
Stockholms Medicinska Biobank
Registration number at IVO: 914
biobankstockholm@regionstockholm.se